Navigation Links
Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN)
Date:5/17/2012

penalty.
  • Patients should be assessed for their clinical risks for opioid abuse or addiction prior to being prescribed opioids.
  • NUCYNTA® ER can be abused in a manner similar to other opioid agonists, legal or illicit. This should be considered when prescribing or dispensing NUCYNTA® ER in situations where the physician or pharmacist is concerned about an increased risk of misuse and abuse. Concerns about abuse and addiction should not prevent the proper management of pain. However, all patients treated with mu-opioid agonists require careful monitoring for signs of abuse and addiction, since use of mu-opioid agonist analgesic products carries the risk of addiction even under appropriate medical use.
  • Drug abusers may attempt to abuse NUCYNTA® ER by crushing, chewing, snorting, or injecting the product. These practices may result in the uncontrolled delivery of NUCYNTA® ER and pose a significant risk to the abuser that could result in overdose and death.
  • NUCYNTA® ER may cause severe hypotension. Patients at higher risk of hypotension include those with hypovolemia or those taking concurrent products that compromise vasomotor tone (eg, phenothiazines, general anesthetics).
  • Patients should be cautioned that NUCYNTA® ER may impair the mental and/or physical abilities required for the performance of potentially hazardous tasks such as driving a car or operating machinery. This is to be expected, especially at the beginning of treatment, at any change of dosage, as well as in combination with alcohol or tranquilizers.
  • NUCYNTA® ER may be expected to have additive effects when used in conjunction with alcohol, other opioids, or illicit drugs that cause CNS depression, because respiratory depression, hypotension, hypertension, and profound sedation, coma, or death may result.
  • NUCYNTA®'/>"/>

    • SOURCE Janssen Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8 9 10 11 12

    Related medicine technology :

    1. NVA237 Phase III GLOW2 Data at American Thoracic Society (ATS) International Conference and Phase II Clinical Trial Update
    2. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
    3. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
    4. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
    5. Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimenda™
    6. Pearl Therapeutics Phase 2b Twice-Daily Dosing Data Suggest Morning and Evening Benefit of PT003 in Patients with COPD
    7. Results Reported for Phase Ib Open-Label Clinical Trial for the Treatment of Depression Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™
    8. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
    9. Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia
    10. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
    11. Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/18/2013)... 2013 Royal Philips (NYSE: PHG, ... Performance Leader in Imaging Equipment in the 2013 Best ... also received Best in KLAS and Best in Category ... 128 Computed Tomography (CT), Ingenia 1.5T and 3.0T ... The annual Best in KLAS Awards: Medical Imaging & ...
    (Date:6/18/2013)... June 18, 2013  Specialty Coating Systems ... in Parylene coating technologies: SCS microRESIST™ Antimicrobial ... of Parylene with antimicrobial properties to effectively ... components. (Logo: http://photos.prnewswire.com/prnh/20130618/DE33772LOGO ... increase and continue to pose a challenge ...
    (Date:6/18/2013)... -- Decision Resources, one of the world,s leading research and ... the past 12 months, 25 percent of surveyed physicians from ... , Italy , Spain ... have been required to change the antiretroviral (ARV) prescription for ... costs. Additionally, more than 40 percent of respondents report that ...
    Breaking Medicine Technology:Philips Named 2013 Overall Performance Leader In Imaging Equipment By KLAS 2Specialty Coating Systems Announces New Antimicrobial Parylene Technology 2One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 2One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 3
    ... Nov. 7, 2011 Zimmer Holdings, Inc. ... agreed to sell $550 million of senior notes in an ... Smith Incorporated, BNP Paribas Securities Corp. and RBS Securities ... LLC, Credit Suisse Securities (USA) LLC, Citigroup Global Markets ...
    ... 7, 2011 ERT (Nasdaq: ERT ), ... President and CEO is scheduled to present at the ... on Nov. 15, 2011 in Las Vegas. ... Company,s corporate website at http://www.ert.com . The webcast ...
    Cached Medicine Technology:Zimmer Holdings, Inc. Agrees to Sell $550 Million of Senior Notes 2ERT to Present at the Citi 2011 Global Health Care Conference on November 15, 2011 2
    (Date:6/18/2013)... Medical Center clinical researchers have launched an innovative ... evaluate the ability of a patient,s own stem ... peripheral arterial disease (PAD). , Led by ... University Hospitals Case Medical Center,s Harrington Heart & ... Western Reserve University School of Medicine, the clinical ...
    (Date:6/18/2013)... Belleville, Ill. (PRWEB) June 18, 2013 More ... older are living with HIV/AIDS, according to the Centers for ... don’t know they are infected. In support of National HIV ... Social Security Disability Insurance (SSDI) representation, the CDC ... HIV testing. , The CDC reports about 50,000 new ...
    (Date:6/18/2013)... 2013 myCNAjobs announces the addition of ... articles, and tips to the Caregiver Resources Center. , ... the 10,000+ retiring baby boomers each day, the need ... job resources has never been greater. myCNAjobs, ... community, recently launched the first-ever free resource center for ...
    (Date:6/18/2013)... 18, 2013 A new $119 million ... burgeoning aquaculture industry is redefining the way consumers get ... most acclaimed personal culinary chefs on the Emerald Coast ... of sustainable seafood and the promising industry of aquaculture. ... days. Many consumers strive to fully partake in the ...
    (Date:6/18/2013)... Pomona, Calif. (PRWEB) June 18, 2013 ... associate professor of Family Medicine for the College of ... of Health Sciences has been elected president of the ... Gov. Edmund G. Brown Jr. appointed Connett, a 1984 ... , OMBC members recently elected Connett to the position ...
    Breaking Medicine News(10 mins):Health News:UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation 2Health News:Allsup Observes National HIV Testing Day June 27 2Health News:Allsup Observes National HIV Testing Day June 27 3Health News:myCNAjobs Adds New Resources to Growing Caregiver Career Center 2Health News:New $119 Million Industry Swimming Up the East Coast 2
    ... likely to be infected with Hepatitis C virus compared ... get treatment for their liver disease because current antiviral ... this epidemiological background, the article by Schaefer and colleagues, ... important study in the field, write Sanjeev Arora and ...
    ... 72 posters, lectures, and mini-symposia given by University of Pennsylvania ... new research findings on the molecular workings of several types ... American Society of Cell Biology takes place on December 1-5, ... Huntington,s Disease: A new role has been discovered for ...
    ... 3 inVentiv Health, Inc.,(Nasdaq: VTIV ) today ... be held Tuesday, December 11th, 2007 in New York ... 9:00 a.m. as announced earlier, and,will conclude at noon, ... business overview, presentations by the,leaders of each of the ...
    ... N.C., Dec. 3 LipoScience, Inc. is pleased to,announce ... of Directors., Mr. Landon has over 30 years ... retiring from active management, Mr. Landon,was Vice President & ... full functional responsibility for all of DuPont,s Medical,Products businesses, ...
    ... research from a lab at Florida State University reveals ... it, resisting temptations to misbehave, our fuel tank is ... , Florida State psychologist Roy F. Baumeister and his ... M. Tice, Florida State, showed this with an experiment ...
    ... An inhaled immune system stimulant protects mice against ... and fungal infections of the lungs, a research ... Texas M. D. Anderson Cancer Center reports at ... have implications for protecting immuno-compromised patients against infection ...
    Cached Medicine News:Health News:Treating patients with psychiatric disorders for hepatitis C 2Health News:Penn talks at ASCB touch on cancer, neurodegenerative diseases, and MD 2Health News:inVentiv Health Provides Updated Information on December 11th Investor Day 2Health News:inVentiv Health Provides Updated Information on December 11th Investor Day 3Health News:Got sugar? Glucose affects our ability to resist temptation 2Health News:Aerosol launches immune response in lungs to wipe out lethal infections 2Health News:Aerosol launches immune response in lungs to wipe out lethal infections 3
    ... ,Offers an average 5:1 increase in usage time ... of a standard cannula. , ,The combination ... ambulatory oxygen patients a superior alternative to liquid ... warranty. , ,NOTE: ...
    Redesigning the World's Oxygen Therapy One Device at a Time. , ,Everything you like about our OXYMATIC 400 Series conservers, only better!...
    ... Accutrol is similar in design to the ... incorporates a temperature probe at the tip ... can accurately determine the patient's core body ... accuracy comparable to a pulmonary artery catheter ...
    ... Ultra Micro Shafts For Insertion Through A ... Light-Weight ... Shafts For A More Comfortable Approach., ,Recessed ... Cap Supplied For Protection Of Jaws During ...
    Medicine Products: